WINDTREE THERAPEUTICS INC (WINT)

Company Profile

Windtree Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Warrington, Pennsylvania and currently employs 15 full-time employees. Windtree Therapeutics, Inc. is a biotechnology company. The firm is focused on advancing early and late-stage therapies for critical conditions and diseases. The Company’s portfolio of product candidates includes istaroxime, a Phase II candidate with SERCA2a activating properties for acute heart failure and associated cardiogenic shock, pre-clinical SERCA2a activators for heart failure and VAR-101 and VAR-102, pre-clinical precision atypical protein kinase C iota (aPKCi) inhibitors that are being developed for potential in rare and broad oncology applications. Istaroxime is a positive inotropic agent that increases myocardial contractility through inhibition of Na+/K+- ATPase with a complimentary mechanism that facilitates myocardial relaxation through activation of the SERCA2a calcium pump on the sarcoplasmic reticulum, enhancing calcium reuptake from the cytoplasm. The company also has a licensing business model with partnership out-licenses in place.

Company Info

WINDTREE THERAPEUTICS INC

2600 Kelly Rd Ste 100

Warrington PENNSYLVANIA 18976

P: 12154889300

CEO: Craig E. Fraser

Employees: 15

Website: https://windtreetx.com/